A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.
Tsang ES, Aggarwal RR, Dhawan MS, Bergsland EK, Alvarez EA, Calabrese S, Pacaud R, Garcia J, Fattah D, Thomas S, Grabowsky J, Moasser MM, Munster PN.
Tsang ES, et al. Among authors: fattah d.
Cancer Res Commun. 2022 Jul 1;2(7):570-576. doi: 10.1158/2767-9764.CRC-22-0028. eCollection 2022 Jul.
Cancer Res Commun. 2022.
PMID: 36923283
Free PMC article.
Clinical Trial.